SYDNEY, July 10, 2025 /PRNewswire/ — BenQ’s professional esports brand ZOWIE proudly announces the official launch of its first ZOWIE Zone in Australia, now open at WY Gaming (Level 1/382 Sussex St, Sydney NSW 2000). This immersive gaming space is designed to deliver a tournament-grade experience for FPS (First-Person Shooter) gamers looking to push their skills to the next level.
The ZOWIE Zone allows FPS players to test and play like a pro with ZOWIE’s latest monitors, the XL2566X+ and XL2586X+, which are used in the highest level of competition such as IEM Melbourne for CS2 and VCT Champions Pacific in Valorant.
ZOWIE Zone Highlights:
- First official ZOWIE Zone in Australia
- Hands-on experience with ZOWIE XL2566X+ / XL2586X+ monitors
- Optimised for FPS titles like CS2, Valorant, and more
- Designed to replicate pro tournament environments
- Located inside the popular WY Gaming esports venue in Sydney CBD
BenQ Australia B2C Head Shawn Zheng comments:
“With the launch of ZOWIE Zone in Sydney, we aim to provide FPS players with a professional-grade environment where they can truly experience the full potential of our esports gear. This marks a key milestone in expanding ZOWIE’s global footprint.”
Visit the ZOWIE Zone Today
The ZOWIE Zone is now available for bookings and walk-ins. Whether you’re a competitive player, streamer, or just a curious enthusiast, you’re welcome to drop by and experience the gear that pros endorse and recommend.
For a limited time, ZOWIE and WY Gaming are offering free game time for our subscribers of the ZOWIE Newsletter. By subscribing, you’ll also be the first to know about the latest information on ZOWIE gear and events.
Location: WY Gaming, Level 1/382 Sussex St, Sydney NSW 2000
Opening Hours: Open 7 days, 10AM – 1AM
Learn more at: zowie.benq.com
ข่าวที่เกี่ยวข้อง
- Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
- Consortium launches cross-regional pilot on post-quantum security with participation from banks and regulatory stakeholders
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
- Amart Furniture to Overhaul Forecasting and Replenishment with RELEX
